Table 4.
Clinical Outcomes Stratified by Lipoprotein(a) Group
| Lp(a) >230 nmol/L (n = 446) |
Lp(a) ≤7 nmol/L (n = 223) |
P Value | |
|---|---|---|---|
| Diagnosis of obstructive CAD | 95 (21.3%) | 28 (12.6%) | 0.006 |
| Revascularization (PCI or CABG) | 92 (20.6%) | 25 (11.2%) | 0.003 |
| Repeat revascularization (PCI or CABG) | 36 (8.1%) | 7 (3.1%) | 0.014 |
| First myocardial infarction | 77 (17.3%) | 22 (9.9%) | 0.011 |
| STEMI | 34 (7.6%) | 8 (3.6%) | 0.042 |
| NSTEMI | 35 (7.8%) | 12 (5.4%) | 0.239 |
| Silent myocardial infarction | 8 (1.8%) | 2 (0.9%) | 0.367 |
| Recurrent myocardial infarction | 26 (5.8%) | 1 (0.4%) | <0.001 |
| STEMI | 11 (2.5%) | 0 (0%) | 0.018 |
| NSTEMI | 15 (3.4%) | 1 (0.4%) | 0.020 |
| Ischemic stroke | 36 (8.1%) | 10 (4.5%) | 0.084 |
| Peripheral arterial disease | 31 (7.0%) | 10 (4.5%) | 0.210 |
Obstructive CAD was defined as the presence of ≥50% stenosis in at least one coronary vessel with a diameter of ≥1.5 mm on invasive coronary angiography, or a history of PCI or CABG. Data are presented as number of patients with percentages in brackets.